Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Devogelaer, JP' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 81 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Ben Sedrine, W; Devogelaer, JP; Kaufman, JM; Goemaere, S; Depresseux, G; Zegels, B; Deroisy, R; Reginster, JY
      Evaluation of the simple calculated osteoporosis risk estimation (SCORE) in a sample of white women from Belgium

      BONE
    2. Banse, X; Devogelaer, JP; Munting, E; Delloye, C; Cornu, O; Grynpas, M
      Inhomogeneity of human vertebral cancellous bone: Systematic density and structure patterns inside the vertebral body

      BONE
    3. Boutsen, Y; Jamart, J; Esselinckx, W; Devogelaer, JP
      Primary prevention of gluccocorticoid-induced osteoporosis with intravenous pamidronate and calcium: A prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone

      JOURNAL OF BONE AND MINERAL RESEARCH
    4. Devogelaer, JP
      Incidentaloma, glucocorticoid excess and low bone mineral density: a coincidence?

      EUROPEAN JOURNAL OF ENDOCRINOLOGY
    5. Reid, DM; Adami, S; Devogelaer, JP; Chines, AA
      Risedronate increases bone density and reduces vertebral fracture risk within one year in men on corticosteroid therapy

      CALCIFIED TISSUE INTERNATIONAL
    6. Alexandersen, P; Toussaint, A; Christiansen, C; Devogelaer, JP; Roux, C; Fechtenbaum, J; Gennari, C; Reginster, JY
      Ipriflavone in the treatment of postmenopausal osteoporosis - A randomizedcontrolled trial

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    7. Goffin, E; Devogelaer, JP; Depresseux, G; de Strihou, CV
      Bone mass evolution after renal transplantation

      KIDNEY INTERNATIONAL
    8. Jardinet, D; Lefebvre, C; Depresseux, G; Lambert, M; Devogelaer, JP; Houssiau, FA
      Longitudinal analysis of bone mineral density in pre-menopausal female systemic lupus erythematosus patients: deleterious role of glucocorticoid therapy at the lumbar spine

      RHEUMATOLOGY
    9. Devogelaer, JP
      Treatment of bone diseases with bisphosphonates, excluding osteoporosis

      CURRENT OPINION IN RHEUMATOLOGY
    10. Eastell, R; Devogelaer, JP; Peel, NFA; Chines, AA; Bax, DE; Sacco-Gibson, N; de Deuxchaisnes, CN; Russell, RGG
      Prevention of bone loss with risedronate in glucocorticoid-treated rheumatoid arthritis patients

      OSTEOPOROSIS INTERNATIONAL
    11. Reid, DM; Hughes, RA; Laan, RFJM; Sacco-Gibson, NA; Wenderoth, DH; Adami, S; Eusebio, RA; Devogelaer, JP
      Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: A randomized trial

      JOURNAL OF BONE AND MINERAL RESEARCH
    12. Reginster, JY; Bruyere, O; Audran, M; Avouac, B; Body, JJ; Bouvenot, G; Brandi, ML; Gennari, C; Kaufman, JM; Lemmel, EM; Vanhaelst, L; Weryha, G; Devogelaer, JP
      Do estrogens effectively prevent osteoporosis-related fractures?

      CALCIFIED TISSUE INTERNATIONAL
    13. Cordier, P; Decruynaere, C; Devogelaer, JP
      Bone mineral density in posttransplantation patients: Effects of physical activity

      TRANSPLANTATION PROCEEDINGS
    14. Blot, L; Marcelis, A; Devogelaer, JP; Manicourt, DH
      Effects of diclofenac, aceclofenac and meloxicam on the metabolism of proteoglycans and hyaluronan in osteoarthritic human cartilage

      BRITISH JOURNAL OF PHARMACOLOGY
    15. Manicourt, DH; Poilvache, P; van Egeren, A; Devogelaer, JP; Lenz, ME; Thonar, EJMA
      Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen andcartilage aggrecan in rheumatoid arthritis but not in osteoarthritis

      ARTHRITIS AND RHEUMATISM
    16. Kaufman, JM; Johnell, O; Abadie, E; Adami, S; Audran, M; Avouac, B; Ben Sedrine, W; Calvo, G; Devogelaer, JP; Fuchs, V; Kreutz, G; Nilsson, P; Pols, H; Ringe, J; Van Haelst, L; Reginster, JY
      Background for studies on the treatment of male osteoporosis: state of theart

      ANNALS OF THE RHEUMATIC DISEASES
    17. Heureux, F; Maiter, D; Boutsen, Y; Devogelaer, JP; Jamart, J; Donckier, J
      Evaluation of glucocorticoid replacement therapy and of their effects on bone mineral density in Addison's disease

      ANNALES D ENDOCRINOLOGIE
    18. Devogelaer, JP; Manicourt, DH
      Osteophytes and osteoarthritis progression. Effects of nonsteroidal antiinflammatory drugs

      OSTEOARTHRITIS AND CARTILAGE
    19. van Pesch, V; Jadoul, M; Lefebvre, C; Lauwerys, BR; Tomasi, JP; Devogelaer, JP; Houssiau, FA
      Clinical significance of antiproteinase 3 antibody positivity in cANCA-positive patients

      CLINICAL RHEUMATOLOGY
    20. Nzeusseu, A; Brion, F; Lefebvre, C; Knoops, P; Devogelaer, JP; Houssiau, FA
      Functional outcome of myositis patients: Can a low-dose glucocorticoid regimen achieve good functional results?

      CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    21. Kaufman, JM; Compston, J; Audran, MA; Avouac, B; Devogelaer, JP; Lemmel, EM; Vanhaelst, L; Reginster, JY
      Recommendations for the registration of drugs intended for use in the treatment of male osteoporosis

      CALCIFIED TISSUE INTERNATIONAL
    22. Manicourt, DH; Poilvache, P; Nzeusseu, A; van Egeren, A; Devogelaer, JP; Lenz, ME; Thonar, EJMA
      Serum levels of hyaluronan, antigenic keratan sulfate, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 change predictably inrheumatoid arthritis patients who have begun activity after a night of bedrest

      ARTHRITIS AND RHEUMATISM
    23. Vande Berg, BC; Malghem, J; Lecouvet, FE; Devogelaer, JP; Maldague, B; Houssiau, FA
      Fat conversion of femoral marrow in glucocorticoid-treated patients - A cross-sectional and longitudinal study with magnetic resonance imaging

      ARTHRITIS AND RHEUMATISM
    24. Manicourt, DH; Altman, RD; Williams, JM; Devogelaer, JP; Druetz-Van Egeren, A; Lenz, ME; Pietryla, D; Thonar, EJMA
      Treatment with calcitonin suppresses the responses of bone, cartilage, andsynovium in the early stages of canine experimental osteoarthritis and significantly reduces the severity of the cartilage lesions

      ARTHRITIS AND RHEUMATISM
    25. DEVOGELAER JP; LECART C; DUPRET P; DENAYER P; DEDEUXCHAISNES CN
      LONG-TERM EFFECTS OF PERCUTANEOUS ESTRADIOL ON BONE LOSS AND BONE METABOLISM IN POSTMENOPAUSAL HYSTERECTOMIZED WOMEN

      Maturitas
    26. HOUSSIAU FA; TOUKAP AN; DEPRESSEUX G; MALDAGUE BE; MALGHEM J; DEVOGELAER JP; BERG BCV
      MAGNETIC-RESONANCE IMAGING-DETECTED AVASCULAR OSTEONECROSIS IN SYSTEMIC LUPUS-ERYTHEMATOSUS - LACK OF CORRELATION WITH ANTIPHOSPHOLIPID ANTIBODIES

      British journal of rheumatology
    27. DEVOGELAER JP
      A RISK-BENEFIT ASSESSMENT OF ALENDRONATE IN THE TREATMENT OF INVOLUTIONAL OSTEOPOROSIS

      Drug safety
    28. HOUSSIAU FA; DEPRESSEUX G; MALGHEM J; DEVOGELAER JP; VANDEBERG BC
      EFFECTS OF GLUCOCORTICOID THERAPY ON PROXIMAL FEMUR MARROW - A LONGITUDINAL MAGNETIC-RESONANCE (MR) STUDY IN SLE AND RA PATIENTS

      Arthritis and rheumatism
    29. REID D; DEVOGELAER JP; HUGHES R; LAAN R; ADAMI S; SACCOGIBSON N; WENDEROTH D
      RISEDRONATE IS EFFECTIVE AND WELL TOLERATED IN TREATING CORTICOSTEROID-INDUCED OSTEOPOROSIS

      Arthritis and rheumatism
    30. HOUSSIAU FA; DELANNOY A; DEVOGELAER JP
      PARADOXICAL IMMUNOLOGICAL EFFECTS OF 2-CDA THERAPY - COMMENT ON THE ARTICLE BY DAVIS ET-AL

      Arthritis and rheumatism
    31. Uwonkunda, MR; Cosyns, JP; Devogelaer, JP; Houssiau, FA
      Glomerular thrombosis: An unusual cause of renal failure in systemic lupuserythematosus

      ACTA CLINICA BELGICA
    32. DEVOGELAER JP; MALGHEM J; STASSE P; DEDEUXCHAISNES CN
      BIOLOGICAL AND RADIOLOGICAL RESPONSES TO ORAL ETIDRONATE AND TILUDRONATE IN PAGETS-DISEASE OF BONE

      Bone
    33. DEVOGELAER JP; FAILLE I; MAINGUET P
      LETTER TO THE EDITOR

      Bone
    34. MARTIN F; LAUWERYS B; LEFEBVRE C; DEVOGELAER JP; HOUSSIAU FA
      SIDE-EFFECTS OF INTRAVENOUS CYCLOPHOSPHAMIDE PULSE THERAPY

      Lupus
    35. DEVOGELAER JP
      HOW DO YOU KNOW WHO NEEDS PREVENTION OR TREATMENT

      Bailliere's clinical rheumatology
    36. LAUWERYS BR; DUFOUR JP; NOEL H; BERG BV; DEVOGELAER JP
      OSTEOPENIA, BONE FRAGILITY AND REFLEX SYMPATHETIC DYSTROPHY SYNDROME IN A MAN WITH URETEROSIGMOIDOSTOMY

      Osteoporosis international
    37. FAVUS M; EMKEY R; LEITE M; DEVOGELAER JP; RODRIGUEZ J; PEVERLY C; KAUR A; SANTORA A
      5-YEAR TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN WITH ORAL ALENDRONATE - EFFECTS ON BONE MASS AND TURNOVER AND SAFETY

      Journal of bone and mineral research
    38. DEVOGELAER JP; DEPRESSEUX G; SCALLIET P; KIRKOVE C
      TAMOXIFEN PROTECTION OF TRABECULAR BONE MASS IN POSTMENOPAUSAL WOMEN SUFFERING FROM BREAST-CANCER

      Journal of bone and mineral research
    39. MUNTING E; SMITZ P; VANSANTE N; DEDEUXCHAISNES CN; VINCENT A; DEVOGELAER JP
      EFFECT OF A STEMLESS FEMORAL IMPLANT FOR TOTAL HIP-ARTHROPLASTY ON THE BONE-MINERAL DENSITY OF THE PROXIMAL FEMUR - A PROSPECTIVE LONGITUDINAL-STUDY

      The Journal of arthroplasty
    40. KAUFMAN JM; DEVOGELAER JP; RAEMAN F; ROZENBERG S; BODY JJ; WESTHOVENS R; REGINSTER JY
      PREVENTION AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS NATIONAL CONSENSUS OF THE BELGIAN-BONE-CLUB NOVEMBER 1996

      Clinical rheumatology
    41. LAUWERYS BR; PUTTEMANS T; HOUSSIAU FA; DEVOGELAER JP
      COLOR DOPPLER SONOGRAPHY OF THE TEMPORAL ARTERIES IN GIANT-CELL ARTERITIS AND POLYMYALGIA-RHEUMATICA

      Journal of rheumatology
    42. LAMBERT M; HUBERT C; DEPRESSEUX G; BERG BV; THISSEN JP; DEDEUXCHAISNES CN; DEVOGELAER JP
      HEMATOLOGICAL-CHANGES IN ANOREXIA-NERVOSA ARE CORRELATED WITH TOTAL-BODY FAT MASS DEPLETION

      The International journal of eating disorders
    43. BOUTSEN Y; JAMART J; ESSELINCKX W; STOFFEL M; DEVOGELAER JP
      PRIMARY PREVENTION OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS WITH INTERMITTENT INTRAVENOUS PAMIDRONATE - A RANDOMIZED TRIAL

      Calcified tissue international
    44. REGINSTER JY; BUFALINO L; CHRISTIANSEN C; DEVOGELAER JP; GENNARI C; RIIS BJ; ROUX C
      DESIGN FOR AN IPRIFLAVONE MULTICENTER EUROPEAN FRACTURE STUDY

      Calcified tissue international
    45. BOSCHI A; SPIRITUS M; CIOFFI M; DEVOGELAER JP; BERGMANS J
      OCULAR NEUROMYOTONIA IN A CASE OF PAGETS-DISEASE OF BONE

      Neuro-ophthalmology
    46. DEVOGELAER JP; DEDEUXCHAISNES CN
      USE OF PAMIDRONATE IN CHRONIC AND ACUTE BONE LOSS CONDITIONS

      Medicina
    47. HOUSSIAU FA; MASCARTLEMONE F; STEVENS M; LIBIN M; DEVOGELAER JP; GOLDMAN M; RENAULD JC
      IL-12 INHIBITS IN-VITRO IMMUNOGLOBULIN PRODUCTION BY HUMAN LUPUS PERIPHERAL-BLOOD MONONUCLEAR-CELLS (PBMC)

      Clinical and experimental immunology
    48. HOUSSIAU FA; MALGHEM J; MALDAGUE BE; DEVOGELAER JP; BERG BV
      MRI BONE-MARROW CHANGES IN SLE - CORRELATION WITH GLUCOCORTICOID INTAKE AND AVASCULAR OSTEONECROSIS

      Arthritis and rheumatism
    49. EMKEY R; MCILWAIN H; FAVUS M; LEITE M; DEVOGELAER JP; RODRIGUEZ J; PEVERLY C; ARNOLD A; KAUR A; SANTORA A
      THE EFFECTS OF ORAL ALENDRONATE ON BONE MASS AND TURNOVER AND SAFETY - 5-YEAR TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN

      Arthritis and rheumatism
    50. DEVOGELAER JP
      ORAL ALENDRONATE INDUCES PROGRESSIVE INCREASES IN BONE MASS OF THE SPINE, HIP, AND TOTAL-BODY OVER 3 YEARS IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS (VOL 18, PG 141, 1996)

      Bone
    51. DEVOGELAER JP; BROLL H; CORREAROTTER R; CUMMING DC; DEDEUXCHAISNES CN; GEUSENS P; HOSKING D; JAEGER P; KAUFMAN JM; LEITE M; LEON J; LIBERMAN U; MENKES CJ; MEUNIER PJ; REID I; RODRIGUEZ J; ROMANOWICZ A; SEEMAN E; VERMEULEN A; HIRSCH LJ; LOMBARDI A; PLEZIA K; SANTORA AC; YATES AJ; YUAN W
      ORAL ALENDRONATE INDUCES PROGRESSIVE INCREASES IN BONE MASS OF THE SPINE, HIP, AND TOTAL-BODY OVER 3 YEARS IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS

      Bone
    52. DEVOGELAER JP; MAINGUET P; FAILLE I
      OSTEOPOROSIS AND LACTOSE-INTOLERANCE

      Revue du rhumatisme
    53. EASTELL R; DEVOGELAER JP; PEEL NFA; GILL C; BAX DE; DEDEUXCHAISNES CN; RUSSELL RGG
      A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO DETERMINE THE EFFECTS OF RISEDONATE ON BONE LOSS IN GLUCOCORTICOID-TREATED RHEUMATOID-ARTHRITISPATIENTS

      Journal of bone and mineral research
    54. COMBE B; AUDRAN M; SEBERT JL; MAZIERES B; MICHAUT S; DEVOGELAER JP; DRICOT J; REGINSTER JY
      EFFICACY OF LONG-TERM TREATMENT OF PAGETS-DISEASE WITH TILUDRONATE 400 MG DAY/

      Journal of bone and mineral research
    55. AUDRAN M; COMBE B; MICHAUT S; DEVOGELAER JP; DRICOT J; REGINSTER JY
      LOW-RISK OF FRACTURES IN LONG-TERM TREATMENT OF PAGETS-DISEASE WITH TILUDRONATE

      Journal of bone and mineral research
    56. DEVOGELAER JP; GOFFIN E; LALAOUI A; SQUIFFLET JP
      BONE-MINERAL DENSITY AFTER RENAL-TRANSPLANTATION - A ROLE FOR IMMUNOSUPPRESSION

      Journal of bone and mineral research
    57. HERMANS C; LEFEBVRE C; DEVOGELAER JP; LAMBERT M
      HYPOCALCEMIA AND CHRONIC ALCOHOL-INTOXICATION - TRANSIENT HYPOPARATHYROIDISM SECONDARY TO MAGNESIUM-DEFICIENCY

      Clinical rheumatology
    58. BOUTSEN Y; DEVOGELAER JP; MALGHEM J; NOEL H; DEDEUXCHAISNES CN
      ANTACID-INDUCED OSTEOMALACIA

      Clinical rheumatology
    59. HOUSSIAU FA; LEFEBVRE C; DEPRESSEUX G; LAMBERT M; DEVOGELAER JP; DEDEUXCHAISNES CN
      TRABECULAR AND CORTICAL BONE LOSS IN SYSTEMIC LUPUS-ERYTHEMATOSUS

      British journal of rheumatology
    60. COMPSTON JE; AUDRAN M; AVOUAC B; BOUVENOT G; DEVOGELAER JP; EASTELL R; FABRIS F; GENNARI C; JONES EA; KAUFMAN JM; LEMMEL EM; MAZZUOLI G; REID DM; RINGE JD; VANHAELST L; ZIEGLER R; REGINSTER JY
      RECOMMENDATIONS FOR THE REGISTRATION OF AGENTS USED IN THE PREVENTIONAND TREATMENT OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS

      Calcified tissue international
    61. HOUSSIAU FA; LAUWERYS B; PUTTEMANS T; DEVOGELAER JP
      COLOR DOPPLER SONOGRAPHY OF THE TEMPORAL ARTERIES IN GIANT-CELL ARTERITIS AND POLYMYALGIA-RHEUMATICA

      Arthritis and rheumatism
    62. HOUSSIAU FA; MASCARTLEMONE F; DEVOGELAER JP; GOLDMAN M; RENAULD JC
      INTERLEUKIN-12 INHIBITS IN-VITRO IMMUNOGLOBULIN PRODUCTION BY SLE PERIPHERAL-BLOOD MONONUCLEAR-CELLS

      Arthritis and rheumatism
    63. HOUSSIAU FA; TOUKAP AN; DEVOGELAER JP; MALDAGUE B; VANDEBERG B
      AVASCULAR BONE NECROSIS IN SLE PATIENTS IS ASSOCIATED WITH GLUCOCORTICOID USE BUT NOT WITH ANTIPHOSPHOLIPID ANTIBODIES

      Arthritis and rheumatism
    64. DOUGADOS M; DEVOGELAER JP; ANNEFELDT M; AVOUAC B; BOUVENOT G; COOPER C; DIEPPE P; ETHGEN D; GARATTINI S; JONES EA; KAUFMAN JM; LEEMING M; LEMMEL EM; LOHMANDER S; MENKES CJ; NUKI G; PAOLOZZI L; PUJOL JP; ROVATI L; SERNI U; SPECTOR T; TSOUDEROS Y; VEYS EM; WESELOH G; REGINSTER JY
      RECOMMENDATIONS FOR THE REGISTRATION OF DRUGS USED IN THE TREATMENT OF OSTEOARTHRITIS

      Annals of the Rheumatic Diseases
    65. HOUSSIAU FA; LEFEBVRE C; VANDENBERGHE M; LAMBERT M; DEVOGELAER JP; RENAULD JC
      SERUM INTERLEUKIN-10 TITERS IN SYSTEMIC LUPUS-ERYTHEMATOSUS REFLECT DISEASE-ACTIVITY

      Lupus
    66. DEVOGELAER JP; LAMBERT M; HUBERT C; DEPRESSUX G
      BODY-COMPOSITION AND BONE-MINERAL CONTENT IN PATIENTS WITH ANOREXIA-NERVOSA

      Journal of bone and mineral research
    67. BOURLET R; DEVOGELAER JP; SOKAL E; SALIEZ A; LAMBOTTE L; DEUXCHAISNES CND
      ROLE OF VITAMIN-D SUPPLEMENTATION IN CHOLESTATIC CIRRHOSIS IN RAT

      Journal of bone and mineral research
    68. HEUSCHLING C; HOUSSIAU FA; JAMAR F; NOEL H; DEVOGELAER JP; DEDEUXCHAISNES CN
      A RARE CASE OF PRIMARY SKELETAL-MUSCLE LYMPHOMA - THE VALUE OF OCTREOTIDE SCINTIGRAPHY

      Clinical rheumatology
    69. BODY J; KAUFMAN JM; DEVOGELAER JP; REGINSTER JY; GEUSENS P; ROZENBERG S
      PREVENTION AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS - NATIONAL CONSENSUS OF THE BELGIAN BONE CLUB 1993-1994 - PREFACE

      Clinical rheumatology
    70. DEVOGELAER JP; DEDEUXCHAISNES CN
      FLUORIDE THERAPY OF TYPE-I OSTEOPOROSIS

      Clinical rheumatology
    71. LAMBERT M; DEPRESSEUX G; BERG BV; DEVOGELAER JP
      TOTAL LEUKOCYTE AND NEUTROPHIL COUNTS IN PATIENTS WITH ANOREXIA-NERVOSA ARE CORRELATED WITH BODY-FAT MASS VALUES

      Blood
    72. ROUX C; GENNARI C; FARRERONS J; DEVOGELAER JP; MULDER H; KRUSE HP; PICOT C; TITEUX L; REGINSTER JY; DOUGADOS M
      COMPARATIVE PROSPECTIVE, DOUBLE-BLIND, MULTICENTER STUDY OF THE EFFICACY OF TILUDRONATE AND ETIDRONATE IN THE TREATMENT OF PAGETS-DISEASE OF BONE

      Arthritis and rheumatism
    73. DEVOGELAER JP; AZRIA M; ATTINGER M; ABBIATI G; CASTIGLIONI C; DEDEUXCHAISNES CN
      COMPARISON OF THE ACUTE BIOLOGICAL ACTION OF INJECTABLE SALMON-CALCITONIN AND AN INJECTABLE AND ORAL CALCITONIN ANALOG (VOL 55, PG 71, 1994)

      Calcified tissue international
    74. DEVOGELAER JP; AZRIA M; ATTINGER M; ABBIATI G; CASTIGLIONI C; DEDEUXCHAISNES CN
      COMPARISON OF THE ACUTE BIOLOGICAL ACTION OF INJECTABLE SALMON-CALCITONIN AND AN INJECTABLE AND ORAL CALCITONIN ANALOG

      Calcified tissue international
    75. DERISQUEBOURG T; DUBOIS P; DEVOGELAER JP; MEYS E; DUQUESNOY B; DEDEUXCHAISNES CN; DELCAMBRE B; MARCHANDISE X
      AUTOMATED COMPUTERIZED RADIOGRAMMETRY OF THE 2ND METACARPAL AND ITS CORRELATION WITH ABSORPTIOMETRY OF THE FOREARM AND SPINE

      Calcified tissue international
    76. NIELENS H; DEVOGELAER JP; MALGHEM J
      OCCURRENCE OF A PAINFUL STRESS-FRACTURE OF THE FEMORAL-NECK SIMULTANEOUSLY WITH 6 OTHER ASYMPTOMATIC LOCALIZATIONS IN A RUNNER

      Journal of Sports Medicine and Physical Fitness
    77. DEVOGELAER JP; CRABBE J; DEDEUXCHAISNES CN
      RELATION OF OSTEOPENIA TO GLUCOCORTICOID REPLACEMENT THERAPY IN ADDISON-DISEASE

      Annals of internal medicine
    78. DEVOGELAER JP; DEDEUXCHAISNES CN; AZRIA M; BLEICHER M; DELONGUEVILLE M; ABBIATI G; CASTIGLIONI C
      ACUTE BIOLOGICAL EFFECTS OF AN ORAL CALCITONIN ANALOG IN PAGETS-DISEASE

      Journal of bone and mineral research
    79. DEVOGELAER JP; DEDEUXCHAISNES CN; AZRIA M; ATTINGER M; ABBIATI G; CASTIGLIONI C
      COMPARISON OF THE ACUTE BIOLOGICAL ACTION OF INJECTABLE SALMON-CALCITONIN AND AN INJECTABLE AND ORAL CALCITONIN ANALOG

      Journal of bone and mineral research
    80. DEVOGELAER JP; DEDEUXCHAISNES CN
      THERAPY AND THE 1990S - OSTEOPOROSIS

      British journal of rheumatology
    81. MALGHEM J; MALDAGUE B; LABAISSE MA; DOOMS G; DUPREZ T; DEVOGELAER JP; VANDEBERG B
      INTRAVERTEBRAL VACUUM CLEFT - CHANGES IN CONTENT AFTER SUPINE POSITIONING

      Radiology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/05/20 alle ore 17:58:16